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This study reflects on the recognised need for more joined-up, high-quality research 
on phytotherapy that addresses the current societal challenges in finding alternatives 
to the use of antibiotics. The study applied a multidisciplinary participatory approach 
in an expert workshop exercise within the FP7 EU IMPRO project. Prior to this study, 
a literature review was elaborated on research in the field of phytotherapy as applied 
to farm animals, cooperation between research bodies and initiatives to reduce the 
use of antibiotics by using phytotherapeutic remedies. The review was delivered to the 
participants of the workshop so as to receive feedback on it and enrich the discussion. 
Different expertise, background in research or veterinary practice, and varying positions 
regarding phytotherapy were the criteria in targeting participants. A structured workshop 
was subsequently organised, with questions to experts addressing scientific validation 
of phytotherapy, effective treatment under farm conditions and necessary developments 
for the future. Challenges identified by the experts were as follows: poor study designs, 
lack of reproducibility of studies, poor standardisation of products, cost–benefit con-
cerns, lack of veterinarian training and poor data availability. To overcome obstacles, the 
need for improved study designs for clinical trials was given priority in order to prove the 
efficacy of remedies and to implement a monitoring system which enables the assess-
ment of the effectiveness of treatments in farm practice. Reflections in this report are 
intended to be a resource for scientists, policy makers and end users for an effective use 
of phytotherapy at farm level.
Keywords: animal health, herbal remedies, efficiency, randomised controlled trials, external validation
inTrODUcTiOn
The need to reduce the use of antibiotics in livestock, due to increased concerns over the spread of 
antibiotic resistance, has raised the interest in phytotherapy (1). However, to the best of authors’ 
knowledge, no studies of the prescription and use of phytotherapeutic remedies for food-producing 
animals by veterinarians in Europe are available. A study of the use of phytotherapy reported that 
590 plant species, deriving from 102 different plant families, are available to be used for animal 
treatments in the EU, although only very few are registered for the treatment of livestock (2). Thus, 
the use of phytotherapeutic products in farm practice is limited. Even in organic agriculture, where 
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phytotherapeutic treatments are promoted by EU Regulation (3), 
phytotherapeutic remedies are administered to a minor extent in 
comparison to antibiotics or antiparasitics (4).
Reasons for the low relevance of phytotherapeutic products 
when treating sick animals are manifold and difficult to grasp. 
Legal uncertainties are assumed to be one of the most sig-
nificant obstacles to the use of phytotherapeutic remedies (5). 
Phytotherapeutic products are not authorised centrally in the 
EU, but by the national institutions. The number of veterinary 
herbal medicines approved in the different EU member states, 
and the extent to which they require veterinary prescription, is 
not known (6). In addition, the concern and difficulties related 
to the patenting of herbal medicines have precluded the financial 
incentives that could be provided to the pharmaceutical industries 
(7). Nevertheless, it is permitted to sell feed additives containing 
plant material in different formulations, with claims concerning 
optimisation of nutrition, support or protection of the physiologi-
cal conditions, unless they do not contain a claim declaring that 
they will prevent, treat or cure a disease (8). Due to their easy 
access, botanical products are primarily sold as feed additives, 
and they may be used as presumed remedies. These conditions 
leave farmers and veterinarians to a large extent without scien-
tific and unbiased assessment of their efficacy. Thus, the use of 
feed additives and non-registered products is often based on the 
experiences and mental associations of those who administer the 
products (6).
Previous studies of the efficacy of phytogenic compounds in 
food-producing animals are highly variable, leading to a general 
uncertainty regarding the efficacy of phytotherapy (9). So far, 
in vitro and experimental studies have dominated the research 
work. In general when field studies were carried out under the 
conditions of commercial farms, the results were not reproduced 
(5). The use of phytotherapeutic products at farm level might also 
be related to the uncertainty as to whether professional skills are 
available to support an effective administration (9).
A large proportion of studies using the same botanical rem-
edies to compare the efficacy of the remedy between the studies 
were classified as uncertain in a systematic review (6). Clearly, 
systematic reviews rely strongly on the quality and quantity of 
primary data (clinical trials), which is low in the field of veterinary 
herbal medicine. Due to the different methods of preparation and 
different parts of plants used in herbal extracts, such reviews may 
not be fully comparable (10) and thus do not provide sufficient 
scientific guidance.
The first aim of this study was to reflect on challenges and 
priorities for an effective use of phytotherapy in livestock. For this 
purpose, a workshop with invited experts from various disciplines 
was organised. As background to the workshop, a review was con-
ducted, collecting information on current procedures (lege artis), 
performing a systematic literature search of in  vivo studies on 
the use of phytotherapy in livestock and distributing a question-
naire in order to assess research collaboration and constraints as 
viewed by institutions engaged in the field of phytotherapy. The 
workshop was organised so as to receive feedback on the review as 
well as to identify important factors influencing the effectiveness 
and use of phytotherapeutics in research and farm practice in 
the European context. The second aim of this study is to define 
a focused future strategic planning on the use and research of 
phytotherapy in livestock.
MaTerials anD MeThODs
Workshop Design and selection of experts
A workshop entitled “Workshop on options and limitations of 
phytotherapy” was organised with the aim of engaging 12 experts. 
The selection of candidates as experts from across Europe was 
based on their scientific and technical expertise and experience. 
The areas of expertise to be covered were as follows: veterinary 
medicine and herd health management in practice (two par-
ticipants), phytotherapy research (2), pharmacology research (1), 
veterinary epidemiology (2), regulatory agencies (2), evidence-
based medicine and animal health and welfare (4). The selection 
was carried out independently by three researchers involved in the 
FP7 EU IMPRO project (www.impro-dairy.eu). The evaluation of 
the expertise of the persons was based on previous publications 
and experience. When approximately 30 experts were identified, 
the IMPRO team discussed the composed list of experts. To foster a 
balance, candidates were classified as neutral, promotors or detrac-
tors of phytotherapy prior to the final selection. The list was agreed 
among the partners of the project. A second round of contacts 
to candidates and invitation letters were sent out to conform the 
final number of experts for the workshop. If the response was 
positive, the following material was provided: an extended agenda 
with information about the workshop and a consent form. The 12 
participants were from different European countries (Great Britain, 
Germany, Spain, Switzerland, Austria, Sweden, Netherlands and 
Denmark). Approximately half of the participants were active in the 
field of phytotherapy, the majority representing researchers but also 
veterinarians practicing phytotherapy as well as representatives of 
the industry. All participants were informed that they should keep 
in mind that they were not representing any organisation. Prior 
to the workshop, each participant received a copy of the scientific 
review that forms the Deliverable 9.2 from the FP7 EU IMPRO 
project (No. 311824), “Report on research projects in the field of 
phytotherapy, cooperation between research bodies and initiatives 
to reduce the use of antibiotics by using phytotherapeutic remedies.”
Procedure
The workshop was arranged in Germany on 12 January 2015. 
The discussion was guided by a professional coach with mod-
eration and group communication skills Dr. Karina Gregory 
(Moderatio®) also experienced in conflict mediation. In order 
not to influence the experts, the research group responsible for 
the review restricted itself to an observing role. The workshop 
was divided into five sessions (Figure 1). In the first session, an 
overview of the IMPRO project was presented, followed by a short 
summary and discussion of the main results and conclusions of 
the review. In the second session, how studies on phytotherapy 
should be designed to enable a valid assessment of efficacy was 
discussed with the participants. This was followed by the third 
session, in which external factors that influence the effective 
use of phytotherapy were reflected upon and explored through 
open discussion on what is necessary to ensure that efficacy is 
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the suggested
recommendation
Individual opinion of experts
Discussion about result (areas 
of agreement and reasons for 
dissensions)
Sesion 1. Review and results
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Sesion 3. External factors
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FigUre 1 | Structure of the workshop and the major topic for each session.
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given under varying practical conditions. The fourth session of 
the workshop was based on the discussions in previous parts 
to identify future steps for an effective use of phytotherapy. In 
this session, the experts individually composed suggestions on 
how the European Commission should proceed on the topic of 
research and use of phytotherapeutic products in farm animals, 
especially in order to reduce the use of antibiotics. Finally, an 
open (non-guided) discussion was scheduled at the end of the 
workshop in order to capture general feedback.
The moderator introduced the different topics by flipcharts, 
collected single aspects and opinions of each expert by modera-
tion cards, and supported the dialogue between the experts. The 
flipcharts were used actively during the workshop and filled in 
during the discussion by the experts. After the workshop, the 
charts in combination with the researcher’s notes were used as a 
protocol. In addition, audio recording was collected as a reference 
and for clarification during the writing process.
resUlTs anD DiscUssiOn
research challenges
Research challenges on what is needed to validate efficacy and 
what prevents achieving effectiveness highlighted by the experts 
are described below.
Poor Study Design
For a large proportion of the studies discussed at the workshop, 
the participants supported the statement that the observed 
effect or lack of an effect within the studies cannot be evaluated 
appropriately due to poor study design, e.g., poor specification of 
content or composition of ingredients and dosage of the applied 
botanical. In both the review and the workshop, it was high-
lighted that randomised clinical trials are important so as to test 
the corresponding hypothesis and for establishing the adequate 
doses. The members of the expert panel agreed that the use of 
phytotherapy also needs to be evaluated by on commercial farm 
trials in order to establish their effectiveness in practice.
Poor Standardisation and Classification of Products
Poor standardisation of products and limited information regard-
ing the composition of the remedies used cause major problems 
with regard to reproducibility. Although standardisation is difficult 
for phytotherapeutic products, as they are complex combinations 
of several phytochemicals, there are guidelines for presenting 
content in a standardised way enabling reproducibility. However, 
the same botanical given to an animal can be categorised as a feed, 
a feed additive or as a veterinary medicinal product, depending on 
the purpose for which it is given, and the required documentation 
between the different categories varies. The necessary require-
ments of documenting content and standardisation of veterinary 
medicinal products make it difficult for the manufacturers to 
protect and patent the product. Consequently, there is a drive for 
selling promising products as feed additives/single feeds with no 
indication for treatment or prevention of diseases, but with unspe-
cific health-supporting claims, as the feed sector is less strictly 
regulated than the medicines sector (6). The participants in the 
workshop expressed a need for clarification of how some botani-
cal products, such as single feeds and feed additives, should be 
categorised, and how a standardised presentation of content can 
be achieved without jeopardising the patentability of the product.
Lack of Reproducibility of Studies
Although most studies tend to conclude that phytotherapeutic 
remedies may have potential, none of the scientific studies have 
been replicated (5). Even though some investigations under 
practical conditions in large-scale animal production have 
shown better responses to treatment than earlier studies under 
controlled experimental conditions (11, 12), with a higher level 
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of hygiene, the figures are not comparable, since certain condi-
tions (i.e., environmental) on commercial farms were different 
(13). The workshop participants have indicated that the use of 
phytotherapy is thus lacking any reproducibility, and the results 
cannot claim to have a relevant external validity.
Cost–Benefit Concerns
Workshop participants considered that it is very expensive to 
develop new phytotherapeutic remedies, while buying antimi-
crobials that are already on the market is expected to be less 
expensive. According to the discussion, this may lead to a more 
ineffective search for alternatives to the existing antibiotics, as 
companies do not see it as economically viable to invest in devel-
oping new remedies as long as cheaper alternatives are available. 
There is a directive (14) that established a regulatory framework 
for traditional herbal medicinal products to meet specific and 
appropriate standards of efficacy, safety and quality, and this 
framework is quite costly for manufacturers. Consequently, the 
approvals of medicinal phytotherapeutic products are associ-
ated with high costs, but combined with small profits from sale, 
discourage companies from developing these types of products.
Lack of (Veterinary) Training
There was disagreement among the participants with respect 
to what extent farmers and lay persons are able to diagnose and 
follow-up treatments. However, all participants saw that clinical 
veterinarians play an important role in supervising, advising and 
educating the farmer, as well as taking the responsibility for the suc-
cess of treatment and the fact that the issues of animal welfare and 
food safety are appropriately taken into account. However, how to 
deal with this issue is interpreted somewhat differently in different 
countries. For example, in Sweden, it is not generally considered 
lege artis for veterinarians to prescribe phytotherapeutic remedies 
that are not approved veterinary medical products, while veterinar-
ians in Germany more frequently use these types of products (6).
Due to the possible risks for animal health and welfare, only 
individuals with appropriate education and training should 
make use of phytotherapy. The possibilities for education in the 
subject of phytotherapy vary considerably between countries 
(15). In a study of Fernández González et al. (9), veterinarians 
or feed advisors from France, Germany, Netherlands and Spain 
using phytotherapy were interviewed. Even those who had used 
phytotherapeutic products for longer time periods had little or 
no formal education on this matter. Currently studies of the 
prescription of phytotherapeutic remedies for food-producing 
animals by veterinarians in Europe are not available. Nor is there 
a generally approved specialisation for veterinary phytotherapy/
herbal medicine in the European Union. Currently, the study of 
botanicals mainly has a place in the subject of toxicology within 
the veterinary curriculum (6). Nowadays, little information 
regarding the administration to animals is available, and how 
to establish effective dosage is largely missing from scientific lit-
erature and textbooks (2). The experts agreed that the possibility 
for interested farmers and veterinarians to gain more knowledge 
is limited and varies between countries in the European Union. 
Tradition, lack of knowledge and education in many parts of 
Europe is limiting the use of these treatment methods (16).
Poor Data Availability
All participants in the workshop noticed that monitoring and 
control of effectiveness of all kinds of treatments in veterinary 
practice in Europe is insufficient. Under these circumstances, it is 
very difficult to prove effectiveness of phytotherapy, as well as of 
conventional treatments, in practice (6).
Further steps for improving research and 
Use of Phytotherapy
The participants in the workshop provided recommendations on 
concrete next steps and operational guidance belonging to differ-
ent discipline areas and impacting on different actors (Figure 2).
Improving Quality of the Study Design
According to the participants, the use of randomised clinical 
control trial study design is also applicable to phytotherapeutic 
products, although they may require some adaptations based 
on the particular substance, use and expected efficacy. The 
experts discussed the importance of choosing products to 
treat diseases and calculating doses based on knowledge of 
practitioners, and other experience bases when designing 
trials. They concluded that relying on experience might also 
give an indication of which effect of the botanical could be 
expected and support this so as to adapt the study design. 
Applying analytical methods identified by the experts, such 
as metabolomics, could help to better identify the ingredients, 
and ensure standardisation and safety of the remedies. Recent 
development of high-throughput and “omics” technologies 
might accelerate studies of the mechanisms, underlying phyto-
genic compounds’ functions and, therefore, guide the effective 
use of the compounds (5).
Development of Specific Guidelines
In order to assess effectiveness in practice, the participants dis-
cussed the need for field trials in which farm-specific conditions 
are taken into account. Different farms have different conditions 
that add to the complexity when designing studies to measure 
the effectiveness of remedies. It would, therefore, be helpful if 
specific guidelines and templates for designing controlled experi-
ments studies on phytotherapeutic remedies were developed with 
established recommendations for dosage and effective use for the 
target species. Guidelines have to be formulated on the stand-
ardisation of contents and on safety analysis for future studies to 
ensure harmonisation.
More Education and Training for the Next  
Generation of Veterinarians
Reintroducing phytotherapy into the curriculum of European 
veterinary education was discussed as an option although associ-
ated with concerns like adaptation to international accreditation 
schemes. As phytotherapeutic products are currently applied at 
different levels (as feed material/additive by farmers or nutrition-
ists; as a remedy or metaphylaxis/prevention–prescription by 
the veterinarian), each application requires adequate knowledge 
and, if products are used, there should be high-quality courses 
available for interested farmers and veterinarians. Experiences 
and knowledge might be gained in the future from the currently 
HERBAL PRODUCTS
Availability, Efficacy, Training
ANIMAL CONDITIONS
Animal Health and Welfare
SOCIETAL IMPACT
Antibiotic reduction, ”natural” product, cost-
effective viability, production yield
Research
MONITORING
POLICY CHANGE
Practitioner/
Final user
Stakeholder
Collaboration
FigUre 2 | Disciplines and impact flows related with the main challenges in phytotherapy.
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existing specialisation for veterinarians in Switzerland and 
Austria in veterinary phytotherapy.
Adapting the Legislation to Better Describing 
Phytotherapeutic Remedies As a Class of Products 
and Harmonise with Human Regulations
An adaptation of the legislation would potentially make it 
possible to register traditional veterinary herbal medicinal 
products through a simplified registration procedure or support 
the registration as health-supporting feed supplements (zoot-
echnical feed additives). Some experts suggested adapting the 
requirements for safety assessments to the specific circumstances 
surrounding botanicals that have been used for a long time and 
that are included in European monographs for human use. One 
suggestion in order to simplify the use was to follow Switzerland 
and exclude phytotherapy from the cascade principle.1 At the 
EU level, a framework should be developed for the regulation of 
substances that reduce the need for or use of antimicrobials to 
solve the conflict arising by the definitions of either a veterinary 
1 Cascade principle: Directive 2004/28/EC clearly states that veterinarians should 
primarily use a product approved for the particular condition and the particular 
species. If botanicals are not approved, this means that veterinarians are not 
allowed to prescribe them for treatment and prophylaxis of diseases.
medicinal product or a feed additive, considering the possible use 
of specific claims (17).
Establishing a European Monitoring System  
for Production Diseases and Treatments
This was a main recommendation all experts agreed upon. There 
is a need to establish a monitoring system for the efficacy of both 
antibiotics and herbal medicines by monitoring the prevalence 
of production diseases, the frequency of treatments and also of 
pathological findings at abattoirs across Europe. This would provide 
essential possibilities for evaluating therapeutic success and the con-
secutive control of effects. A monitoring system would also make it 
possible to follow the impacts of health improving measures (like 
herbal treatments, but also other measures like increased biosecu-
rity) on specific farms over time, taking into account different farm 
characteristics, management routines, feeding regimes, etc. Given 
the ongoing obstacles to the availability of data, diagnostic labo-
ratories appear to provide the most readily available data sources 
for syndromic surveillance in relation to production diseases (18).
Making the Development of New Products and 
Production of Phytotherapeutic Remedies Attractive 
in Terms of Cost-Effectiveness for Manufacturers
Incentives for companies to perform clinical trials with herbal 
medicines should be established through a period of data 
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protection or protection of composition of treatments. The 
experts suggested a period of 5 years. It is important to establish 
research conditions for non-patentable common goods (e.g., 
pure drugs and easily available herbs), based on identified and 
standardised ingredients.
For the development of new products, research supported by 
external funding has to address standards of quality, safety and 
efficacy in parallel with the development of specific guidelines 
and protocols that help to produce appropriate study designs and 
product standardisation. Another request is to provide a post-
authorisation monitoring system for herbal products so as to be 
able to assess to what extent they are reliable as an alternative to 
antibiotics.
More financial support is needed, apart from that by pharma-
ceutical companies, in the view of experts. Similar results were 
obtained in the questionnaire survey of the review, in which 
insufficient support by funding bodies was identified as a main 
constraint in research work (6). The workshop participants rec-
ommended focusing such funding on the proof of efficacy with 
respect to specific indications where antibiotics have been widely 
used, such as in the case of prophylactic use for the most prevalent 
disease problems in pig and poultry.
Strengthen Collaboration in Research
The participants in the workshop also recommended the 
support of research comprising internal (study design) and 
external (efficacy at farm) validation. Stakeholders, e.g., farm-
ers and their veterinarians, should be able to identify and ask 
important (research) questions, the researcher would acquire 
the required knowledge using trials with an appropriate study 
design, and would evaluate scientific results, while the stake-
holder, e.g., practitioner, would apply and assess the results 
on the farms by monitoring and reporting them back. This 
would correspond with the five steps according to the cycle of 
evidence-based veterinary medicine: Ask, Acquire, Appraise, 
Apply, and Assess (19).
The major outputs of the workshop were in line with those 
described in a recent event at the EMA and EFSA Joint Scientific 
Opinion on measures to reduce the need to use antimicrobial 
agents in animal husbandry in the European Union, and the 
resulting impacts on food safety (RONAFA) (17). In this report, 
developing new effective antimicrobials or alternatives for treat-
ment, promoting research and innovation as well as improving 
communication, education and training were identified as key 
areas to be addressed.
cOnclUsiOn
The major obstacles to overcoming an inappropriate use of the 
phytotherapy are as follows: (1) the conflict between missing 
results concerning efficacy and the interests of the farmers to 
use feed additives without prescriptions by the veterinarian; 
(2) the request for better education of veterinarians when, on 
the other hand, the prerequisites of evidence-based efficacy are 
not available; and (3) the conflict between commercial interests 
and the tasks of the authorities to ensure animal welfare and 
food safety. Only coordinated and sustained efforts (including 
long-term funded research) by all players in the livestock sec-
tor as well as developers of regulatory framework will allow 
possibilities to release the potential therapeutic ability of 
phytotherapy.
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